French pharmaceutical company Sanofi has entered exclusive talks to sell a 50% stake in its consumer health business Opella to U.S. private equity firm CD&R, with Bpifrance acquiring a 2% share. The deal, valued at around €16 billion, includes guarantees on job retention and production in France and is expected to finalize by the second quarter of 2025.